Vivanza Biosciences Limited (VIVANZA.BO)
INR 2.25
(-1.32%)
INR 2.25
(-1.32%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 50.02 Million INR | -36.32% |
| 2022 | 78.56 Million INR | 44.07% |
| 2021 | 54.52 Million INR | 58.05% |
| 2020 | 34.5 Million INR | 9.01% |
| 2019 | 31.65 Million INR | -29.39% |
| 2018 | 44.82 Million INR | 4.51% |
| 2017 | 42.88 Million INR | 32.94% |
| 2016 | 32.26 Million INR | 579.47% |
| 2015 | 4.74 Million INR | 10.84% |
| 2014 | 4.28 Million INR | 11.68% |
| 2013 | 3.83 Million INR | 10.56% |
| 2012 | 3.46 Million INR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 60.67 Million INR | 0.0% |
| 2024 Q1 | - INR | -100.0% |
| 2023 FY | 50.02 Million INR | -36.32% |
| 2023 Q1 | 1.7 Million INR | -97.83% |
| 2023 Q2 | 50.85 Million INR | 2889.71% |
| 2023 Q4 | 50.02 Million INR | 2668.46% |
| 2023 Q3 | 1.8 Million INR | -96.45% |
| 2022 Q1 | -26.8 Million INR | -149.15% |
| 2022 Q4 | 78.56 Million INR | 0.0% |
| 2022 FY | 78.56 Million INR | 44.07% |
| 2022 Q3 | - INR | 0.0% |
| 2021 Q4 | 54.52 Million INR | 298.14% |
| 2021 Q2 | 29.27 Million INR | 194.66% |
| 2021 Q1 | -30.92 Million INR | -189.64% |
| 2021 FY | 54.52 Million INR | 58.05% |
| 2021 Q3 | -27.52 Million INR | -194.01% |
| 2020 Q2 | 33.99 Million INR | 222.42% |
| 2020 Q3 | -31.61 Million INR | -192.99% |
| 2020 FY | 34.5 Million INR | 9.01% |
| 2020 Q1 | -27.76 Million INR | -187.74% |
| 2020 Q4 | 34.5 Million INR | 209.15% |
| 2019 Q4 | 31.64 Million INR | 219.18% |
| 2019 Q1 | -30 Million INR | -166.93% |
| 2019 FY | 31.65 Million INR | -29.39% |
| 2019 Q2 | 33.61 Million INR | 212.03% |
| 2019 Q3 | -26.55 Million INR | -179.01% |
| 2018 Q2 | 43.9 Million INR | 248.03% |
| 2018 Q4 | 44.82 Million INR | 249.54% |
| 2018 Q1 | -29.65 Million INR | -169.15% |
| 2018 Q3 | -29.97 Million INR | -168.27% |
| 2018 FY | 44.82 Million INR | 4.51% |
| 2017 Q1 | 3.19 Million INR | -90.1% |
| 2017 Q2 | 41.34 Million INR | 1194.96% |
| 2017 FY | 42.88 Million INR | 32.94% |
| 2017 Q3 | 324 Thousand INR | -99.22% |
| 2017 Q4 | 42.88 Million INR | 13137.34% |
| 2016 Q2 | 18.13 Million INR | 5943.33% |
| 2016 Q4 | 32.26 Million INR | 3014.18% |
| 2016 Q3 | 1.03 Million INR | -94.29% |
| 2016 FY | 32.26 Million INR | 579.47% |
| 2016 Q1 | 300 Thousand INR | -93.68% |
| 2015 Q3 | 494 Thousand INR | -89.15% |
| 2015 Q2 | 4.55 Million INR | 785.99% |
| 2015 Q1 | 514 Thousand INR | -88.0% |
| 2015 FY | 4.74 Million INR | 10.84% |
| 2015 Q4 | 4.74 Million INR | 861.19% |
| 2014 Q1 | 32 Thousand INR | -99.17% |
| 2014 FY | 4.28 Million INR | 11.68% |
| 2014 Q4 | 4.28 Million INR | 566.21% |
| 2014 Q3 | 643 Thousand INR | -84.52% |
| 2014 Q2 | 4.15 Million INR | 12884.38% |
| 2013 Q3 | 54 Thousand INR | -98.51% |
| 2013 FY | 3.83 Million INR | 10.56% |
| 2013 Q2 | 3.61 Million INR | 3625.77% |
| 2013 Q4 | 3.83 Million INR | 7003.47% |
| 2013 Q1 | 97 Thousand INR | -97.2% |
| 2012 FY | 3.46 Million INR | 0.0% |
| 2012 Q4 | 3.46 Million INR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| DECIPHER LABS LIMITED | -93.13 Million INR | 153.712% |
| Gujarat Themis Biosyn Limited | -53.88 Million INR | 192.84% |
| Ishita Drugs and Industries Limited | -48.09 Million INR | 204.008% |
| MedPlus Health Services Limited | 8.67 Billion INR | 99.424% |
| ANG Lifesciences India Limited | 671.01 Million INR | 92.545% |
| Add-Shop E-Retail Limited | 116.24 Million INR | 56.966% |
| Bacil Pharma Limited | 569 Thousand INR | -8691.916% |
| BDH Industries Limited | -164.47 Million INR | 130.416% |
| Beryl Drugs Limited | 48.7 Million INR | -2.706% |
| Cian Healthcare Limited | 544.97 Million INR | 90.82% |
| Chemo Pharma Laboratories Limited | -6.05 Million INR | 925.784% |
| Concord Drugs Limited | 164.48 Million INR | 69.587% |
| Deccan Health Care Limited | -7.07 Million INR | 806.981% |
| Gujarat Terce Laboratories Limited | 37.76 Million INR | -32.47% |
| Hindustan Bio Sciences Limited | 25.21 Million INR | -98.411% |
| Jenburkt Pharmaceuticals Limited | -791.91 Million INR | 106.317% |
| KIMIA BIOSCIENCES LIMITED | 431.72 Million INR | 88.413% |
| Kwality Pharmaceuticals Limited | 921.75 Million INR | 94.573% |
| Makers Laboratories Limited | 172.59 Million INR | 71.015% |
| Medi-Caps Limited | -3.21 Million INR | 1656.503% |
| Panchsheel Organics Limited | -157.82 Million INR | 131.698% |
| Parmax Pharma Limited | 51.8 Million INR | 3.443% |
| Parnax Lab Limited | 787.61 Million INR | 93.648% |
| Patidar Buildcon Limited | 25.12 Million INR | -99.101% |
| Phaarmasia Limited | -4.89 Million INR | 1121.564% |
| Vikram Thermo (India) Limited | 38.62 Million INR | -29.517% |
| Sanjivani Paranteral Limited. | -85.95 Million INR | 158.204% |
| SHAMROCK INDUSTRIAL CO.LTD. | -9.31 Million INR | 637.336% |
| Smruthi Organics Limited | 111.28 Million INR | 55.049% |
| Source Natural Foods and Herbal Supplements Limited | -58.58 Million INR | 185.389% |
| SUDARSHAN PHARMA INDUSTRIES LI | 1.04 Billion INR | 95.222% |
| Trident Lifeline Limited | 117.56 Million INR | 57.446% |
| Transchem Limited | -3.16 Million INR | 1681.6% |
| Trinity League India Limited | -12 Thousand INR | 416983.333% |
| Tyche Industries Limited | -788.94 Million INR | 106.341% |
| Vista Pharmaceuticals Limited | 78.7 Million INR | 36.438% |
| PRAVEG LIMITED | -434.98 Million INR | 111.501% |
| Sastasundar Ventures Limited | -297.24 Million INR | 116.83% |
| Sunil Healthcare Limited | 625.4 Million INR | 92.001% |
| Syschem (India) Limited | 3.53 Million INR | -1316.365% |
| Zenith Healthcare Limited | -25.45 Million INR | 296.512% |
| Zenlabs Ethica Limited | 139.54 Million INR | 64.151% |
| Mercury Laboratories Limited | -26.72 Million INR | 287.16% |
| SHELTER PHARMA LIMITED | -44.62 Million INR | 212.106% |
| Vasundhara Rasayans Limited | -76.15 Million INR | 165.691% |
| Bharat Immunologicals & Biologicals Corporation Limited | 689.39 Million INR | 92.743% |
| Roopa Industries Limited | 216.01 Million INR | 76.841% |
| PANJON LTD. | -12.8 Million INR | 490.584% |
| Pharmaids Pharmaceuticals Limited | 37.28 Million INR | -34.161% |
| TIAAN CONSUMER LIMITED | 13.44 Million INR | -272.079% |
| Anuh Pharma Limited | -69.8 Million INR | 171.663% |
| Crestchem Limited | -1.45 Million INR | 3550.069% |
| Emmessar Biotech & Nutrition Limited | -60.73 Million INR | 182.372% |
| Sandu Pharmaceuticals Limited | -11.43 Million INR | 537.673% |
| Fredun Pharmaceuticals Limited | 1.04 Billion INR | 95.208% |
| Trimurthi Limited | -1.17 Million INR | 4345.968% |
| Shukra Pharmaceuticals Limited | -68.26 Million INR | 173.282% |
| Norris Medicines Limited | 214.86 Million INR | 76.717% |
| Veerhealth Care Limited | -2.38 Million INR | 2197.526% |
| Lactose (India) Limited | 373.97 Million INR | 86.623% |
| OXYGENTA PHARMACEUTICAL LIMITE | 571.32 Million INR | 91.244% |
| Ambalal Sarabhai Enterprises Limited | 132.1 Million INR | 62.13% |
| Gennex Laboratories Limited | -552.54 Million INR | 109.054% |
| Denis Chem Lab Limited | -236.28 Million INR | 121.172% |
| Colinz Laboratories Limited | -64.3 Million INR | 177.797% |
| Godavari Drugs Limited | 530.02 Million INR | 90.561% |
| Zenotech Laboratories Limited | -196.85 Million INR | 125.412% |
| Shree Ganesh Remedies Limited | 201.85 Million INR | 75.217% |
| Bharat Parenterals Limited | 1.48 Billion INR | 96.64% |
| Coral Laboratories Limited | -612.82 Million INR | 108.163% |
| Evoq Remedies Limited | 41.14 Million INR | -21.576% |
| Kerala Ayurveda Limited | 447.82 Million INR | 88.829% |
| KOBO BIOTECH LIMITED | 1.39 Billion INR | 96.414% |
| Natural Capsules Limited | 956.68 Million INR | 94.771% |
| Auro Laboratories Limited | 252.51 Million INR | 80.189% |